Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zhongzhen Zeng"'
Autor:
Ying Gao, Jundong Wang, Maoyuan Zhao, Ting Xia, Qingsong Liu, Nianzhi Chen, Wenhao Liao, Zhongzhen Zeng, Fengming You, Jinhao Zeng
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Blocking and even reversing gastric precancerous lesions (GPL) is a key measure to lower the incidence of gastric cancer. Atractylenolide III (AT-III) is a mainly active component of the Atractylodes rhizome and has been widely used in tu
Externí odkaz:
https://doaj.org/article/0d43d37e863948a3b9b0849e0eb65b91
Autor:
Jinhao Zeng, Xiao Ma, Ziyi Zhao, Yu Chen, Jundong Wang, Yanwei Hao, Junrong Yu, Zhongzhen Zeng, Nianzhi Chen, Maoyuan Zhao, Jianyuan Tang, Daoyin Gong
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Seeking novel and effective therapies for gastric precancerous lesions (GPL) is crucial to reducing the incidence of gastric cancer. Ginsenoside Rb1 (GRb1) is a major ginsenoside in ginseng and has been proved to possess multiple bioactiv
Externí odkaz:
https://doaj.org/article/b50e5680bea44896a8b9eadd67d850d7
Autor:
Qiao Zheng, Yan Zhang, Lanlan Zhang, Nianzhi Chen, Gang Zhang, Maoyuan Zhao, Wenhao Liao, Zhongzhen Zeng, Yujie Wei, Gang Zhou, Jianyuan Tang, Ziyi Zhao
Background: Colorectal cancer, as a general malignancy of the digestive system, has long constituted a threat to the health of the population and the development of the social economy. It has been widely recognized that exploiting a drug with weaken
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38a055100e5e6086f3af834920018c25
https://doi.org/10.21203/rs.3.rs-1568315/v1
https://doi.org/10.21203/rs.3.rs-1568315/v1
Autor:
Ziyi Zhao, Jinhao Zeng, Jundong Wang, Yu Chen, Jianyuan Tang, Maoyuan Zhao, Nianzhi Chen, Daoyin Gong, Qiao Zheng, Zhongzhen Zeng, Gang Zhang, Qing Nian
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 145, Iss, Pp 112086-(2022)
Ginsenoside Rg3 (GRg3) is a ginsenoside extracted from Panax ginseng. GRg3 displays multiple pharmacological properties, such as antitumor, anti-inflammatory, antioxidative and antifibrotic properties. However, whether GRg3 inhibits angiogenesis in g
Autor:
Jundong Wang, Maoyuan Zhao, Qiao Zheng, Nianzhi Chen, Yun Yuan, Jianyuan Tang, Yu Guo, Jinhao Zeng, Gang Zhang, Qingsong Liu, Shangbin Lv, Ting Xia, Zhongzhen Zeng, Xiao Ma, Ziyi Zhao, Yulin Qi, Yu Chen
Background:Many specific biomarkers and target genes of gastric cancer have been identified, but the research areas on the characterization of epigenetic and transcriptional landscape in the process of gastric carcinogenesis, known as the trilogy fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5f92f35e10810419d722992453a119c
https://doi.org/10.21203/rs.3.rs-910498/v1
https://doi.org/10.21203/rs.3.rs-910498/v1